Shares of Panacea Biotech slumped around 5 percent intraday on October 13 after the US Food and Drug Administration slapped a Form 483 with nine observations on its biologics manufacturing ...

Panacea Biotech slumps 5% after US FDA issues 9 observations on Baddi facility

A group called the Incubate Coalition, comprising the venture capital firms that bankroll most biotech startups, is pressing US lawmakers to extend by four years the time that pills can be on the ...

Biotech investors push to extend time before pills are subject to price negotiations

While global demand growth in the segment remained generally healthy, the US based biotech segment is showing signs of slowed growth year-on-year as companies adjust to a new funding environment.

Syngene MD and CEO Jonathan Hunt expects US Biotech segments recovery by Q4 after having cut company's FY24 guidance

Tonix Pharmaceuticals Holding Corp. today announced that a study published in the Journal Nature1 by faculty at the Center for Transplantation Sciences, Massachusetts General Hospital (MGH) in collaboration with biotechnology company, eGenesis, utilized ...

Pharm Country

Biotech investment fund reckons sector is poised for growth but Australia not ready to capitalise on growth Per capita, Australia leads biomedical research productivity but invests substantially ...

Global biotech sector set to boom but where are Aussie investors?

On the last day, Concord Biotech had a BSE volume of 22,598 shares, with a closing price of ₹1143.85.

Concord Biotech share price Today Live Updates : Concord Biotech closed today at ₹1174.9, down -1.25% from yesterday's ₹1189.8

An ambitious plan to harness Serbian scientific expertise and private partners from among the world’s biggest pharma, genetics and healthcare companies has divided expert opinion. Some see it as ...

With Big Private Backers, Serbian Biotech Plan Stirs Hopes and Fears

Novo Nordisk on Monday announced that it is acquiring the late-stage investigational hypertension drug ocedurenone from Singapore-based biotech KBP Biosciences for up to $1.3 billion. Ocedurenone is currently being assessed in the Phase III CLARION-CKD ...

Novo in $1.3B Deal Buys Late-Stage Hypertension Drug from Singapore Biotech

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the ...

Cell and gene therapy CEOs share survival strategies amid biotech slump

A Hong Kong company has said leukaemia patients will be able to receive a cancer treatment at a lower cost, after it became the first biotechnology firm in the city to receive a licence to locally ...

RIZOFLORA BIOTECHNOLOGY

rizoflora.com.br

employees

Since n.d.

COMPANY RANKING

RIZOFLORA BIOTECHNOLOGY

EVERGREEN INDEX #2257

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Rizoflora Biotechnology

Rizoflora Biotechnology WIKI

Apply to get your Tech Company News Page live on gzht888.com today!

RIZOFLORA BIOTECHNOLOGY

rizoflora.com.br

employees

Since n.d.

COMPANY RANKING

RIZOFLORA BIOTECHNOLOGY

EVERGREEN INDEX #2257

RELATED COMPANIESRANK

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Rizoflora Biotechnology

Rizoflora Biotechnology WIKI

Apply to get your Tech Company News Page live on gzht888.com today!